The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2006
DOI: 10.1016/j.joca.2005.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts

Abstract: These results suggest that IL-17 is an in vitro stimulator of angiogenic factor release, both by its own action and by cooperating with TNF-alpha.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
83
0
4

Year Published

2009
2009
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 121 publications
(94 citation statements)
references
References 43 publications
3
83
0
4
Order By: Relevance
“…Moreover, the levels of Th17 cells were positively correlated with microvessel density in tumors (87). By acting on stromal cells and fibroblasts, IL-17 induces a wide range of angiogenic mediators (88,89), including vascular endothelial growth factor (VEGF), that markedly promote inflammatory and tumor angiogenesis (90). IL-17 is able to up-regulate VEGF production by fibroblasts and therefore promote fibroblast-induced new vessel formation in inflammation and tumors.…”
Section: Regulation Of Th17 Differentiation In Tumorsmentioning
confidence: 99%
“…Moreover, the levels of Th17 cells were positively correlated with microvessel density in tumors (87). By acting on stromal cells and fibroblasts, IL-17 induces a wide range of angiogenic mediators (88,89), including vascular endothelial growth factor (VEGF), that markedly promote inflammatory and tumor angiogenesis (90). IL-17 is able to up-regulate VEGF production by fibroblasts and therefore promote fibroblast-induced new vessel formation in inflammation and tumors.…”
Section: Regulation Of Th17 Differentiation In Tumorsmentioning
confidence: 99%
“…8 Since IL-6 and IL-23 are both involved in the IL-23/IL-17 pathway, in the present study we aimed to elucidate the role of IL-17 in cervical cancer. The function of IL-17 is tissue-and contextdependent and includes activation of nuclear factor-kB (NFkB), 9 vascular endothelial growth factor (VEGF) production and angiogenesis, [10][11][12][13][14] stimulation of pro-inflammatory cytokine production, 15 neutrophil recruitment, 16 and formation of epithelial tight junctions. 17 While it is clear that IL-17 plays a prominent role in both the protection of the host from invading extracellular pathogens and the destruction of host tissues in several chronic inflammatory and auto-immune disorders, there is controversy about its role in cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Heparin-binding EGF (HB-EGF), a potent mitogen and chemotactic factor for smooth muscle cells in the EGF family (14), is expressed mainly in the airway epithelium and is significantly upregulated in asthmatic airways (15). In vitro, there is also evidence that IL-17 can stimulate HB-EGF secretion by synovial fibroblasts (16). These observations led us to investigate the role of the EGFR pathway in Th17-related airway remodeling.…”
mentioning
confidence: 99%